Long-term disease-free survival of patients with radically resected thymomas: Relevance of cell-cycle protein expression

Cancer

Volumn 104, Issue 10, 2005, Pages 2063-2071

  Mineo, Tommaso Claudio ^a   Ambrogi, Vincenzo ^a,c   Mineo, Davide ^a   Baldi, Alfonso ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cell cycle proteins; Masaoka staging; Thoracic surgery; Thymomas; Who classification

Indexed keywords

CELL CYCLE PROTEIN; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADOLESCENT; ADULT; AGED; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; STERNOTOMY; SURVIVAL TIME; THORAX SURGERY; THYMECTOMY; THYMOMA; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CELL CYCLE PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYMOMA; THYMUS NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 27644511733     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21433     Document Type: Review

References (30)

1. Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg. 1999;230:562-572.
2. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991;51:152-156.
3. Blumberg D, Port IL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60:908-913.
4. Regnard J-F, Magdeleinat P, Dromer C. Prognostic factors and long-term results after thymoma resection-a series of 307 patients. J Thorac Cardiovasc Surg. 1996;112:376-384.
5. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485-2492.
6. Masaoka A, Yamakawa Y, Hiwa H, et al. Thymectomy and malignancy. Eur J Cardiothorac Surg. 1994;8:251-253.
7. Shimosato Y. Controversies surrounding the subclassification of thymoma. Cancer. 1994;74:542-544.
8. Lardinois D, Rechsteiner R. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg. 2000;69:1550-1555.
9. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg. 2003; 126:1134-1140.
10. Rosai J, Levine GD. Tumors of the thymus. In: Harlan I, Ferminger MD, editors. Atlas of tumor pathology, 2nd series. Fascicle 13. Washington, DC: The Armed Forces Institute of Pathology, 1976:1-221.
11. Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg. 1961;42:424-444.
12. Marino M, Muller-Hermelink HK. Thymomas and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol. 1985;407:119-149.
13. Kornstein MJ. Thymoma classification-my opinion. Am J Clin Pathol. 1999;112:304-307.
14. Suster S, Moran CA. Thymoma classification. The ride of the Valkyries? Am J Clin Pathol. 1999;112:308-310.
15. Harris NL, Muller Hermelink HK. Thymoma classification. A siren's song of simplicity. Am J Clin Pathol. 1999;112:299-303.
16. Rosai J, Sobin LH. Histological typing of tumors of the thymus. In: World Health Organization, editors. International histological classification of tumors, 2nd ed. Berlin: Springer-Verlag, 1999:1-65.
17. Chen G, Marx A, Wen-Hu C, et al. New WHO classification predicts prognosis of thymic epithelial tumors. A clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95:420-429.
18. Kondo K, Yoshizawa K, Tsuyuguchi M, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77:1183-1188.
19. Strobel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004;22:1501-1509.
20. Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma. A multi-institutional retrospective review of 103 patients. Cancer. 2002;94:1405-1413.
21. Singhal S, Shrager JB, Rosenthal DI, LiVolsi VA, Kaiser LR. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg. 2003;76:1635-1642.
22. Inoue M, Starostik P, Zettl A, et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res. 2003;63:3708-3715.
23. Sherr CS. Cancer cell cycles. Science. 1996;274:1672-1677.
24. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors. Oncogene. 1995;11:211-219.
25. Kirsch DG, Kastan MB. Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol. 1998; 16:3158-3168.
26. Esposito V, Baldi A, Tonini G, et al. Analysis of cell-cycle regulator proteins in non-small cell lung cancer. J Clin Pathol. 2004;57:58-63.
27. Monden Y, Nakahara K, Iioka S, et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg. 1985;39:165-169.
28. Dziuba SJ, Curran WJ Jr. The radiotherapeutic management of invasive thymomas. Chest Surg Clin N Am. 2001;11:457-466.
29. Mangi AA, Wright CD, Allan JS, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg. 2002;74: 1033-1037
30. Okumura M, Ohta M, Tateyama H, et al. The WHO Health Organization histologic classification system reflects the oncologic behavior of thymoma. Cancer. 2002;94:624-632.